1984
DOI: 10.1111/j.1600-0609.1984.tb02180.x
|View full text |Cite
|
Sign up to set email alerts
|

p69,71 Antigen Complex Detected by Monoclonal Antibody Leu 1 in the Identification of Particular Stages of Malignant B‐Cell Differentiation

Abstract: Lymphomatous cell samples from 86 patients with B-cell neoplasia (34 chronic lymphocytic leukaemia, 8 hairy-cell leukaemia, 5 prolymphocytic leukaemia, 20 immunocytic lymphoma, 9 centrocytic lymphoma, 3 centroblastic/centrocytic lymphoma, 3 lymphoblastic lymphoma, 1 plasma cell leukaemia and 3 plasmacytoma) were studied using the monoclonal antibody Leu 1, detecting a p69,71 antigen complex present on nearly all thymocytes, most (> 85 %) peripheral T-lymphocytes as well as some malignant B-cells. Furthermore, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

1985
1985
1988
1988

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 21 publications
0
1
0
Order By: Relevance
“…Thus, it has been reported that neoplastic CLL cells may be recognized by polyclonal anti-T heteroantisera (10, 11) and may occasionally bear sheep erythrocyte receptors (12,13,14,15). Furthermore, it is well-established that the T1 (CD5) and TQl/Leu8 antigens are expressed on the great majority of CLL B-lymphocytes (16,17,18,19) and it is now generally thought that the normal counterpart of CLL may be a Tl+/SIg+ B-cell localized in the follicles of lymphoid tissues (20) and foetal spleen (21). The 65Kd glycoprotein (CDS) is therefore widely used as a specific and diagnostic marker for CLL.…”
mentioning
confidence: 99%
“…Thus, it has been reported that neoplastic CLL cells may be recognized by polyclonal anti-T heteroantisera (10, 11) and may occasionally bear sheep erythrocyte receptors (12,13,14,15). Furthermore, it is well-established that the T1 (CD5) and TQl/Leu8 antigens are expressed on the great majority of CLL B-lymphocytes (16,17,18,19) and it is now generally thought that the normal counterpart of CLL may be a Tl+/SIg+ B-cell localized in the follicles of lymphoid tissues (20) and foetal spleen (21). The 65Kd glycoprotein (CDS) is therefore widely used as a specific and diagnostic marker for CLL.…”
mentioning
confidence: 99%